Brief: Hls Therapeutics Appoints Tim Hendrickson As CFO
06/09/2018 11:48
Sept 6 (Reuters) - HLS Therapeutics Inc HLS.V :
* HLS THERAPEUTICS APPOINTS TIM HENDRICKSON AS CFO
* HLS THERAPEUTICS - HENDRICKSON TO TAKE ON ROLE OF CFO
EFFECTIVE
IMMEDIATELY.
Source text for Eikon: ID:nCNWrfqgja
Further company coverage: HLS.V
(Reuters.Briefs@thomsonreuters.com)
Recent news on HLS Therapeutics
See all newsCanada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group
Canada's HLS Therapeutics Q1 revenue rises on Vascepa growth, reaffirms 2026 guidance
Canada's HLS Therapeutics Q4 revenue slightly beats on Vascepa strength
Brief: Esperion Partner announces HLS Therapeutics received approval Of NILEMDO for the reduction of LDL-cholesterol in canadians at risk of cardiovascular disease
Brief: HLS Therapeutics announces Health Canada approval of NILEMDO for the reduction of LDL-Cholesterol in Canadians at risk of cardiovascular disease